...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.
【24h】

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.

机译:分子标记可改善周围T细胞淋巴瘤的诊断和血管免疫母细胞T细胞淋巴瘤的预后。

获取原文
获取原文并翻译 | 示例
           

摘要

Peripheral T-cell lymphoma (PTCL) is often challenging to diagnose and classify. Gene expression profiling was performed on 144 cases of PTCL and natural killer cell lymphoma and robust molecular classifiers were constructed for angioimmunoblastic T-cell lymphoma (AITL), anaplastic lymphoma kinase-positive (ALK(+)) anaplastic large-cell lymphoma (ALCL), and adult T-cell leukemia/lymphoma. PTCL-unclassifiable was molecularly heterogeneous, but we were able to identify a molecular subgroup with features of cytotoxic T lymphocytes and a poor survival compared with the remaining PTCL-not otherwise specified cases. Many of the pathologic features and substantial components of the molecular signature of AITL are contributed by the follicular dendritic cells, B-cell, and other stromal components. The expression of Th17-associated molecules in ALK(+) ALCL was noted and may represent aberrant activation of Th17-cell differentiation by abnormal cytokine secretion. Adult T-cell leukemia/lymphoma has a homogeneous molecular signature demonstrating high expression of human T-lymphotropic virus type 1-induced genes. These classifiers reflect the biology of the tumor cells as well as their microenvironment. We also constructed a molecular prognosticator for AITL that appears to be largely related to the microenvironmental signature, and the high expression of 2 immunosuppressive signatures are associated with poor outcome. Oncogenic pathways and tumor-host interactions also were identified, and these findings may lead to better therapies and outcome in the future.
机译:外周T细胞淋巴瘤(PTCL)通常难以诊断和分类。对144例PTCL和自然杀伤细胞淋巴瘤进行基因表达谱分析,并构建了强大的分子分类器,用于血管免疫母细胞T细胞淋巴瘤(AITL),间变性淋巴瘤激酶阳性(ALK(+))间变性大细胞淋巴瘤(ALCL) ,以及成人T细胞白血病/淋巴瘤。不可分类的PTCL在分子上是异质的,但与其余PTCL除外(未另作说明)相比,我们能够鉴定出具有细胞毒性T淋巴细胞特征且存活率较差的分子亚组。滤泡树突状细胞,B细胞和其他基质成分可导致AITL分子标记的许多病理学特征和实质性成分。注意到Th17相关分子在ALK(+)ALCL中的表达,可能代表异常细胞因子分泌引起Th17细胞分化的异常激活。成人T细胞白血病/淋巴瘤具有均一的分子特征,证明了人类T淋巴病毒1型诱导基因的高表达。这些分类器反映了肿瘤细胞的生物学及其微环境。我们还构建了AITL的分子预后因子,该分子预后因子似乎与微环境特征密切相关,而2种免疫抑制特征的高表达与不良预后相关。还确定了致癌途径和肿瘤-宿主相互作用,这些发现可能会在将来导致更好的疗法和结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号